Aspects of early lymphoid commitment

Current Opinion in Hematology

Volumn 10, Issue 3, 2003, Pages 203-207

  Wang, Hongfang ^a   Spangrude, Gerald J ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Hematopoietic lineage commitment; Lymphocyte progenitors; Notch receptors; Thymic selection

Indexed keywords

INTERLEUKIN 7 RECEPTOR; LIGAND; NOTCH RECEPTOR; RECEPTOR; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

B LYMPHOCYTE; BONE MARROW; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL MIGRATION; HEMATOPOIETIC STEM CELL; LYMPHOID CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STEM CELL; T LYMPHOCYTE; THYMUS; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINEAGE; HEMATOPOIESIS; HUMANS; LYMPHOCYTES; SIGNAL TRANSDUCTION;

EID: 0037623469     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200305000-00002     Document Type: Review

References (44)

1. Miyamoto T, Iwasaki H, Reizis B, et al.: Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell 2002, 3:137-147. This article presents a comprehensive analysis of sets of genes expressed at defined stages of hematopoietic development, using highly defined and purified cell populations and reverse transcription polymerase chain reaction.
2. Hu M, Krause D, Greaves M, et al.: Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev 1997, 11:774-785.
3. Schebesta M, Heavey B, Busslinger M: Transcriptional control of B-cell development. Curr Opin Immunol 2002, 14:216-223.
4. Scott EW, Simon MC, Anastasi J, et al.: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265:1573-1577.
5. DeKoter RP, Singh H: Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 2000, 288:1439-1441.
6. DeKoter RP, Lee HJ, Singh H: PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 2002, 16:297-309. The mechanism by which PU.1 deletion inhibits lymphoid lineage specification was determined in this study to be at least partially owing to a failure of interleukin-7 receptor expression in the absence of PU.1. Coupled with the observation that graded expression of PU.1 regulates myeloid versus lymphoid lineage choices [5], this study establishes the mechanism of early lymphoid lineage commitment.
7. Anderson MK, Weiss AH, Hernandez-Hoyos G, et al.: Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity 2002, 16:285-296.
8. Sigvardsson M, O'Riordan M, Grosschedl R: EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 1997, 7:25-36.
9. Urbanek P, Wang ZQ, Fetka I, et al.: Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 1994, 79:901-912.
10. Nutt SL, Urbanek P, Rolink A, et al.: Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev 1997, 11:476-491.
11. Schaniel C, Bruno L, Melchers F, et al: Multiple hematopoietic cell lineages develop in vivo from transplanted Pax5-deficient pre-B I-cell clones. Blood 2002, 99:472-478. This study evaluates the in vivo potential of Pax5-deficient pre-B I-cell clones, demonstrating a broad range of differentiation potentials that include erythroid development in addition to natural killer cell, dendritic cell, and myeloid lineages.
12. Schaniel C, Gottar M, Roosnek E, et al.: Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones. Blood 2002, 99:2760-2766. Pax5-deficient pre-B I-cell clones exhibit extensive self-renewal in these studies, as evidenced by serial transplantation experiments. In addition, the clones colonize the bone marrow even after multiple transplantations and thus in many ways resemble a developmentally arrested version of the primitive hematopoietic stem cell.
13. Nutt SL, Heavey B, Rolink AG, et al.: Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999, 401:556-562.
14. Mikkola I, Heavey B, Horcher M, et al.: Reversion of B cell commitment upon loss of Pax5 expression. Science 2002, 297:110-113.
15. Eberhard D, Jimenez G, Heavey B, et al.: Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J 2000, 19:2292-2303.
16. Milili M, Gauthier L, Veran J, et al.: A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes. Immunology 2002, 106:447-455.
17. Allman D, Punt JA, Izon DJ, et al.: An invitation to T and more: notch signaling in lymphopoiesis. Cell 2002, 109(suppl):S1-S11.
18. Ellisen LW, Bird J, West DC, et al.: TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991, 66:649-661.
19. Pear WS, Aster JC, Scott ML, et al.: Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996, 183:2283-2291.
20. Pui JC, Allman D, Xu L, et al.: Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999, 11:299-308.
21. Radtke F, Wilson A, Stark G, et al.: Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999, 10:547-558.
22. Wilson A, MacDonald HR, Radtke F: Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med 2001, 194:1003-1012. This study established that the control of T/B lineage fate regulated by Notch-1 is independent of thymic homing, supporting the interpretation that the B lineage is a default pathway adopted by lymphoid progenitor cells unable to complete T-cell maturation.
23. Wolfer A, Wilson A, Nemir M, et al.: Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta lineage thymocytes. Immunity 2002, 16:869-879. This study, along with a second article from the same group [24••], establishes that individual members of the Notch family may play specific roles at distinct stages of T-cell development. In this study, inactivation of Notch-1 shortly after T-lineage specification is shown to selectively inhibit α-β T-cell development, while leaving development of γ-δ cells largely unaffected.
24. neg thymocyte development has no effect on the subsequent expression of CD4 and CD8 or on the maturation and survival of thymocytes. These results, coupled with previous studies using overexpression of activated Notch-1, suggest that Notch family members other than Notch-1 may play important roles in late stages of T-cell development.
25. Rothenberg EV: Notchless T cell maturation? Nat Immunol 2001, 2:189-190.
26. Jaleco AC, Naves H, Hooijberg E, et al.: Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med 2001, 194:991-1002. Differential effects of ligands for Notch suggest a mechanism by which the same receptor can respond to distinct environmentals to direct specific lineage pathways.
27. Schmitt TM, Zúñiga-Pflucker JC: Induction of T cell development from hematopoietic progenitor cells by Delta-like-1 in vitro. Immunity 2002, 17:749-756. The specific role of the thymus in directing T lineage development has been questioned for decades. By expressing the Notch ligand Delta-like-1 in the OP9 cell line, these workers have succeeded in establishing an in vitro model of T cell commitment and differentiation that is independent of primary thymic stromal cells. The OP9 cell line, which was derived from the op/op mutant mouse and thus does not produce macrophage colony-stimulating factor, is a key feature of the model system.
28. Koch U, Lacombe TA, Holland D, et al.: Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1. Immunity 2001, 15:225-236. This study demonstrates that multiple levels of regulation may be involved in the control of T-cell differentiation by the Notch pathway, in agreement with results obtained in model organisms. The function of lunatic fringe is to modify the Notch-1 receptor, which alters its ability to respond to ligand stimulation.
29. Izon DJ, Aster JC, He Y, et al.: Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity 2002, 16:231-243. This study demonstrates that interference of Notch-1 signaling by Deltex1 in lymphoid progenitor cells suppresses T-lineage development while promoting B lineage development. The mechanism by which Deltex1 mediates this effect involves displacement of transcriptional coactivators from the nuclear complex of Notch-1 with other transcription factors. Thus, Notch-1 activity can be regulated at multiple levels in developing lymphocytes.
30. French MB, Koch U, Shaye RE, et al.: Transgenic expression of numb inhibits notch signaling in immature thymocytes but does not alter T cell fate specification. J Immunol 2002, 168:3173-3180.
31. Kawamata S, Du C, Li K, et al.: Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations. Oncogene 2002, 21:3855-3863.
32. Kawamata S, Du C, Li K, et al.: Notch1 perturbation of hemopoiesis involves non-cell-autonomous modifications. J Immunol 2002, 168:1738-1745. After transduction of bone marrow cells with activated Notch-1, both the transduced and the nontransduced cells exhibited inhibition of B-cell development. The production of soluble factors by the transduced cells mediated this effect. This study demonstrates that Notch-1 overexpression can affect neighboring cells in a non-cell autonomous manner.
33. Radtke F, Wilson A, Ernst B, et al.: The role of Notch signaling during hematopoietic lineage commitment. Immunol Rev 2002, 187:65-74.
34. Allman D, Aster JC, Pear WS: Notch signaling in hematopoiesis and early lymphocyte development. Immunol Rev 2002, 187:75-86.
35. Ivanova NB, Dimos JT, Schaniel C, et al.: A stem cell molecular signature. Science 2002, 298:601-604.
36. Kondo M, Weissman IL, Akashi K: Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
37. Medina KL, Garrett KP, Thompson LF, et al.: Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol 2001, 2:718-724.
38. Igarashi H, Gregory SC, Yokota T, et al.: Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 2002, 17:117-130. This paper reports the characterization of early lymphoid progenitor cells, which appear to be the earliest lymphocyte progenitor cells isolated from bone marrow to date. Transient expression of RAG1 during early natural killer cell development firmly establishes the developmental relationship between the innate and adaptive immune systems.
39. Gounari F, Aifantis I, Martin C, et al.: Tracing lymphopoiesis with the aid of a pTalpha-controlled reporter gene. Nat Immunol 2002, 3:489-496.
40. Santori FR, Kieper WC, Brown SM, et al.: Rare, structurally homologous self-peptides promote thymocyte positive selection. Immunity 2002, 17:131-142.
41. Anderson MS, Venanzi ES, Klein L, et al.: Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298:1395-1401. This is a breakthrough study that establishes a mechanism by which self-antigens expressed in peripheral tissues are presented as tolerogenic signal in the thymus.
42. Katsura Y: Redefinition of lymphoid progenitors. Nature Rev Immunol 2002, 2:127-132.
43. Montecino-Rodriguez E, Leathers H, Dorshkind K: Bipotential B-macrophage progenitors are present in adult bone marrow. Nat Immunol 2001, 2:83-88.
44. Lu M, Kawamoto H, Katsube Y, et al.: The common myelolymphoid progenitor: a key intermediate stage in hemopoiesis generating T and B cells. J Immunol 2002, 169:3519-3525. The results presented in this publication argue that erythroid/megakaryocyte lineages segregate from myeloid/lymphoid lineages before the emergence of lymphoid lineage-specified progenitors.